JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.74B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$8.51B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$6.03B |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$4.86B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.63B |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.02B |
| 3 |
Palantir
PLTR
|
+$2.14B |
| 4 |
Shopify
SHOP
|
+$2.1B |
| 5 |
Robinhood
HOOD
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.29% |
| 2 | Technology | 22.42% |
| 3 | Healthcare | 8.64% |
| 4 | Financials | 8.63% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4101
PUT
Teladoc Health
TDOC
$1B
| $1.64M | ﹤0.01% |
320,000
| – | – |
2025 Q3
2 quarters
|
|
4102
CVR Energy
CVI
$5.51B
| $1.64M | ﹤0.01% |
47,056
-309,831
| -87% | -$7.96M |
2013 Q2
51 quarters
|
|
4103
CALL
BioMarin Pharmaceuticals
BMRN
$11.1B
| $1.64M | ﹤0.01% |
30,000
| – | – |
2025 Q4
1 quarter
|
|
|
4104
PUT
BioMarin Pharmaceuticals
BMRN
$11.1B
| $1.64M | ﹤0.01% |
30,000
| – | – |
2025 Q4
1 quarter
|
|
4105
Martin Midstream Partners
MMLP
$85.3M
| $1.64M | ﹤0.01% |
592,219
-23,369
| -4% | -$65.3K |
2021 Q1
20 quarters
|
|
4106
Cognyte Software
CGNT
$645M
| $1.64M | ﹤0.01% |
206,342
-232,929
| -53% | -$1.92M |
2021 Q1
20 quarters
|
|
4107
Grocery Outlet
GO
$1.15B
| $1.63M | ﹤0.01% |
240,885
+70,002
| +41% | +$608K |
2019 Q2
27 quarters
|
|
4108
PUT
Xenon Pharmaceuticals
XENE
$3.68B
| $1.63M | ﹤0.01% |
+29,400
| New | +$1.35M |
2026 Q1
0 quarters
|
|
4109
CALL
Mercado Libre
MELI
$86B
| $1.62M | ﹤0.01% |
1,000
-5,500
| -85% | -$10.6M |
2024 Q1
8 quarters
|
|
|
LIF
4110
Life360
LIF
$3.51B
| $1.62M | ﹤0.01% |
42,475
-11,622
| -21% | -$601K |
2024 Q2
7 quarters
|
|
4111
WisdomTree US Quality Growth Fund
QGRW
$3.22B
| $1.61M | ﹤0.01% |
31,533
+4,013
| +15% | +$229K |
2024 Q1
8 quarters
|
|
4112
Cannae Holdings
CNNE
$674M
| $1.61M | ﹤0.01% |
145,438
-62,679
| -30% | -$841K |
2017 Q4
33 quarters
|
|
4113
PUT
Snap
SNAP
$9.44B
| $1.61M | ﹤0.01% |
400,000
-1,106,100
| -73% | -$6.51M |
2025 Q3
2 quarters
|
|
4114
Annexon
ANNX
$794M
| $1.61M | ﹤0.01% |
323,894
+270,165
| +503% | +$1.52M |
2020 Q3
22 quarters
|
|
|
MTA
4115
Metalla Royalty & Streaming
MTA
$859M
| $1.6M | ﹤0.01% |
263,689
+113,407
| +75% | +$897K |
2024 Q3
6 quarters
|
|
|
DFSD
4116
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.27B
| $1.59M | ﹤0.01% |
33,380
+7,092
| +27% | +$341K |
2023 Q3
10 quarters
|
|
4117
Stock Yards Bancorp
SYBT
$2.44B
| $1.59M | ﹤0.01% |
24,390
-18,401
| -43% | -$1.23M |
2013 Q2
51 quarters
|
|
|
TWO
4118
DELISTED
Two Harbors Investment
TWO
| $1.59M | ﹤0.01% |
141,222
+55,598
| +65% | +$622K |
2013 Q2
51 quarters
|
|
|
IEAG
4119
Infinite Eagle Acquisition Corp
IEAG
$443M
| $1.58M | ﹤0.01% |
+157,793
| New | +$1.58M |
2026 Q1
0 quarters
|
|
4120
CALL
Weatherford International
WFRD
$5.7B
| $1.57M | ﹤0.01% |
+17,000
| New | +$1.6M |
2026 Q1
0 quarters
|
|
4121
Orrstown Financial Services
ORRF
$820M
| $1.57M | ﹤0.01% |
44,204
-16,288
| -27% | -$590K |
2017 Q4
33 quarters
|
|
4122
iShares ESG Aware MSCI USA Growth ETF
EGUS
$28.7M
| $1.57M | ﹤0.01% |
+34,083
| New | +$1.73M |
2026 Q1
0 quarters
|
|
|
SLNO
4123
DELISTED
Soleno Therapeutics
SLNO
| $1.57M | ﹤0.01% |
51,480
-64,037
| -55% | -$2.51M |
2020 Q2
23 quarters
|
|
4124
US Treasury 10 Year Note ETF
UTEN
$260M
| $1.57M | ﹤0.01% |
36,018
+34,766
| +2,777% | +$1.53M |
2025 Q1
4 quarters
|
|
4125
FT Vest Laddered Moderate Buffer ETF
BUFZ
$1.08B
| $1.56M | ﹤0.01% |
60,325
+60,305
| +301,525% | +$1.6M |
2025 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2026 Portfolio in Review
As of Q1 2026, JP Morgan Chase held 8,085 positions worth $1.56T, down 2.2% from $1.59T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase deployed $90.5B of net new capital in Q1 2026, opening 727 new positions and adding to 3,199 existing holdings. Its largest new stake was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $8.63B trimmed.
- JP Morgan Chase's largest Q1 2026 buy was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $9.74B increase.
- JP Morgan Chase's biggest Q1 2026 reduction was Microsoft, cutting an estimated $8.63B.
- JP Morgan Chase fully exited CyberArk in Q1 2026, selling an estimated $307M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.56T portfolio in Q1 2026.
- JP Morgan Chase opened 727 new positions and closed 604 in Q1 2026.
- JP Morgan Chase's portfolio value fell 2.2% quarter-over-quarter to $1.56T.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.